Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2012/0071425 USES OF MANNOSE-6-PHOSPHATE
There is provided the use of mannose-6-phosphate, or a salt, precursor or analogue thereof, for providing and/or maintaining a consistent skin colour,...
2012/0071424 PHARMACEUTICAL COMPOSITION USED IN PROPHYLAXIS OR TREATMENT OF HYPERPROLIFERATIVE SKIN CONDITIONS AND MALIGNANT...
Disclosed is a novel use of phytosphingosine. More particularly, disclosed are a composition for preventing or treating hyper-proliferative skin diseases...
2012/0071423 Heterotricyclic AMPA Receptor Antagonists for Treatment of Epilepsy, Pain, and Other Neurological Disorders and...
Disclosed are heterotricyclic compounds, pharmaceutical compositions, methods of treatment, and methods for selectively antagonizing a glutamate receptor. The...
2012/0071422 Therapeutic application of isolated naturally-occuring soluble truncated forms of IL-23 receptor
The present invention relates to an isolated naturally-occurring soluble truncated IL-23R.alpha. protein, which is a translated protein resulting from a mRNA...
2012/0071421 THERAPY WITH CLOSTRIDIUM PERFRINGENS ENTEROTOXIN TO TREAT OVARIAN AND UTERINE CANCER
The invention discloses high levels of receptors for Clostridium perfringens enterotoxin (CPE) have been found in ovarian cancer and uterine cancer tissue...
2012/0071420 MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS
The invention is directed to a modified T cell receptor (TCR) comprising an amino acid sequence of a wild-type (WT) TCR with no more than three amino acid...
2012/0071419 Target-Specific Non-Antibody Protein and Method for Preparing the Same
The present invention relates to a method for preparing a target-specific non-antibody protein, and more particularly, to a method for preparing a ...
2012/0071418 Inhibitors of Human EZH2 and Methods of Use Thereof
The invention relates to inhibition of wild-type and certain mutant forms of human histone methyltransferase EZH2, the catalytic subunit of the PRC2 complex...
2012/0071417 METHODS OF INHIBITING CANCER CELL GROWTH WITH HDAC INHIBITORS AND METHODS OF SCREENING FOR HDAC10 INHIBITORS
Methods of inhibiting cancer cell growth using HDAC10 inhibitors are provided. Methods of treating cancer in a subject using HDAC10 inhibitors are also...
2012/0071416 LOW FREQUENCY GLATIRAMER ACETATE THERAPY
A method of alleviating a symptom of relapsing-remitting multiple sclerosis in a human patient suffering from relapsing-remitting multiple sclerosis or a...
2012/0071415 DOMINANT NEGATIVE MUTANTS OF SAM68 FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY (SMA)
The present invention relates to the use of dominant negative mutants of Sam68 for the manufacture of a medicament for the treatment of spinal muscular atrophy,...
2012/0071414 METHOD FOR PRODUCING AND USING ACTIVE PRINCIPLES OF LIMESTONE
The present invention relates to a method for extracting organic molecules and/or organic minerals from a limestone material, including placing said limestone...
2012/0071413 TREATMENT OF CHRONIC NEPHROPATHIES USING SOLUBLE COMPLEMENT RECEPTOR TYPE I (sCR1)
A method is disclosed for treating nephropathies involving undesired alternative pathway complement activation by administration of a complement inhibitory...
2012/0071412 METHODS OF USING MACROCYCLIC AGONISTS OF THE GHRELIN RECEPTOR FOR TREATMENT OF GASTROINTESTINAL MOTILITY DISORDERS
The present invention provides novel conformationally-defined macrocyclic compounds that have been demonstrated to be selective agonists of the ghrelin receptor...
2012/0071411 LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS WHICH ARE LYOPHILIZED OR IN A FORM CAPABLE OF BEING LYOPHILIZED
A composition including a peptide agent including amino acid sequence LKKTET [SEQ ID NO: 1] or LKKTNT [SEQ ID NO: 2], a conservative variant thereof, or a...
2012/0071410 CALCITONIN PRODUCTS AND THERAPIES FOR TREATING INFLAMMATORY OR DEGENERATIVE DISEASES
Calcitonin products and therapies for treating inflammatory or degenerative diseases are disclosed herein. The pharmaceutical compositions disclosed herein...
2012/0071409 Colloidal Liposomal Compositions and Methods
A formulation delivery system is disclosed. When configured as a pro-liposome oral tablet, the tablet comprises a blend of at least one Iiposome forming...
2012/0071408 FORMULATIONS FOR ACHIEVING WEIGHT LOSS
A formulation of human chorionic gonadotropin (HCG) for promoting weight loss comprising reconstituted HCG in an amount sufficient to promote weight loss; at...
2012/0071407 METHOD OF TREATING WOUNDS
A novel method of treating a wound is provided. The method comprises administering a therapeutically effective amount of periostin to the wound.
2012/0071406 MODIFIED VEGF-A WITH IMPROVED ANGIOGENIC PROPERTIES
The present invention is directed to methods and compositions for making and using chimeric polypeptides that comprise a VEGFR-2 ligand. The chimeric molecules...
2012/0071405 COMPOSITION OF INHIBITING PATHOLOGICAL ANGIOGENESIS
The present invention provides a pharmaceutical composition for inhibiting pathologic angiogenesis and/or cell proliferative disorder. The pharmaceutical...
2012/0071404 STIMULATION OF PROLIFERATION OF PLURIPOTENTIAL STEM CELLS THROUGH ADMINISTRATION OF PREGNANCY ASSOCIATED COMPOUNDS
The present invention provides for a method for stimulating the proliferation of pluripotential stem cells in a mammal comprising administration of pregnancy...
2012/0071403 Methods for Treating Type 2 Diabetes in Patients Resistant to Previous Treatment with other Anti-Diabetic Drugs...
The invention provides methods for treating a patient having type 2 diabetes who has failed on previous regimens of one or more oral and/or injectable...
2012/0071402 Protease Stabilized, Pegylated Insulin Analogues
Novel PEGylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain...
2012/0071401 AMYLIN AGONIST COMPOUNDS FOR ESTROGEN-DEFICIENT MAMMALS
Provided herein are methods to treat estrogen deficiency in mammals by administering amylin agonist compounds. Also provided herein are methods to treat obesity...
2012/0071400 LIPID METABOLISM-IMPROVING REAGENT
Our objective is to provide a novel lipid metabolism-improving reagent effective in preventing and treating hyperlipidemia and obesity and to provide this...
2012/0071399 SULFATION OF WNT PATHWAY PROTEINS
Provided is a composition comprising a peptide comprising amino acids and/or amino acid analogs comprising a continuous sequence of a sclerostin fragment...
2012/0071398 ANTI-MICROBIAL PEPTIDES
The present invention relates to peptides comprising amino acids according to Formula I ((X).sub.l(Y).sub.m).sub.n (I) wherein l, m and n are integers from 0 to...
2012/0071397 Methods for Hematopoietic Stem Cell Transplantation
The present invention provides methods for treating a subject undergoing hematopoietic stem cell transplantation, methods for increasing a subject's resistance...
2012/0071396 Compositions and Methods for Inhibiting the Interaction Between CFTR and CAL
The present invention features compositions and methods for increasing the cell surface expression of degradation-prone CFTR proteins and preventing or treating...
2012/0071395 TREATMENT OF MAMMALIAN PHYSIOLOGICAL REACTION OF IgE ANTIBODIES PRESENT IN SAID MAMMAL UPON CONTACT WITH THE...
A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with...
2012/0071394 NOVEL POLYPEPTIDES AND USE THEREOF
The present invention provides a polypeptide having a biological activity of the Chemotaxis Inhibitory Protein of Staphylococcus aureus (`CHIPS`), the...
2012/0071393 Mutant CyaA Polypeptides and Polypeptide Derivatives Suitable for the Delivery of Immunogenic Molecules Into a Cell
The invention relates to mutant CyaA/E570Q+K860 polypeptides suitable for use as proteinaceous vectors for delivering one or more molecules of interest into a...
2012/0071392 BENEFIT AGENT CONTAINING DELIVERY PARTICLE
The present invention relates to benefit agent containing delivery particles, compositions comprising said particles, and processes for making and using the...
2012/0071391 BENEFIT AGENT CONTAINING DELIVERY PARTICLE
The present invention relates to benefit agent containing delivery particles, compositions comprising said particles, and processes for making and using the...
2012/0071390 DETERGENT COMPOSITION CONTAINING BIO-DERIVED 1,3-PROPANEDIOL AND ITS CONJUGATE ESTERS
Biodegradable detergent compositions comprising 1,3-propanediol are provided, and the 1,3-propanediol in the composition is biologically derived. The...
2012/0071389 BETAINE FUNCTIONALIZED ALKYL POLYGLUCOSIDES FOR ENHANCED FOOD SOIL REMOVAL
A cleaning composition including a betaine functionalized alkyl polyglucoside, a water conditioning agent, an acid source, a solvent, and water. In one...
2012/0071388 POLY SULFONATE FUNCTIONALIZED ALKYL POLYGLUCOSIDES FOR ENHANCED FOOD SOIL REMOVAL
A cleaning composition including a primarily C.sub.12 poly sulfonate functionalized alkyl polyglucoside, a water conditioning agent, an acid source, a solvent,...
2012/0071387 Soap Saver
A soap saver comprises an original soap bar and a soap fragment. The original soap bar comprises a cavity. The cavity comprises a predetermined shape, a cavity...
2012/0071386 POLY QUATERNARY FUNCTIONALIZED ALKYL POLYGLUCOSIDES FOR ENHANCED FOOD SOIL REMOVAL
A cleaning composition including a poly quaternary functionalized alkyl polyglucoside, a water conditioning agent, an acid source, a solvent, and water. In one...
2012/0071385 QUATERNARY FUNCTIONALIZED ALKYL POLYGLUCOSIDES FOR ENHANCED FOOD SOIL REMOVAL
A cleaning composition including a primarily C.sub.12 quaternary functionalized alkyl polyglucoside, a water conditioning agent, an acid source, a solvent, and...
2012/0071384 LAUNDRY COMPOSITION FOR TREATMENT OF SUNSCREEN STAINS BASED ON EXTENDED CHAIN SURFACTANTS
The invention discloses synergistic combinations of surfactants blends and cleaning composition. In certain embodiments a surfactant system is disclosed which...
2012/0071383 LIQUID DETERGENT COMPOSITION WITH ABRASIVE PARTICLES
The present invention relates to a dishwashing composition comprising abrasive particles and a suspending aid selected from the group consisting of crystalline...
2012/0071382 NON-FLUOROPOLYMER SURFACE PROTECTION COMPOSITION
The present invention encompasses a surface treatment composition which comprises a polyorganosiloxane fluid-silicone resin mixture and a carrier. The...
2012/0071381 PROCESS FOR THE PREPARATION OF A SPRAY POWDER COMPRISING ONE OR MORE GLYCINE-N,N-DIACETIC ACID DERIVATIVES AND...
A process for the preparation of a spray-dried powder containing at least one glycine-N,N-diacetic acid compound of a formula MOOC--CHR--N(CH.sub.2COOM).sub.2,...
2012/0071380 LIQUID CLEANING COMPOSITION
The present invention relates to a liquid, cleaning composition comprising coloured abrasive cleaning particles.
2012/0071379 LIQUID CLEANING COMPOSITION
The present invention relates to a liquid, cleaning composition comprising abrasive cleaning particles.
2012/0071378 LIQUID CLEANING COMPOSITION
The present invention relates to a liquid, cleaning composition comprising abrasive cleaning particles.
2012/0071377 ENGINE CLEANING COMPOSITION AND METHOD FOR CLEANING THE ENGINE
The present invention provides a method of cleaning an engine having at least one combustion chamber, and the method includes the steps of providing an engine...
2012/0071376 Monitoring Cleaning of Surfaces
A method for monitoring cleaning of a surface includes applying an amount of transparent indicator material to an area of a surface and measuring the amount of...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.